Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia
Introduction
There is evidence that the increasing prevalence of obesity seen over the past decade is continuing at a rapid pace. Data from the recent 1999–2000 National Health and Nutrition Examination Survey (NHANES; available online) show that nearly 65% of the adult US population are overweight, as defined by a body mass index (BMI) greater than 25 kg/m2, as compared to 56% seen in NHANES III, which was conducted between 1988 and 1994 (Flegal et al., 2000). Serious health risks can be associated with excess body weight (National Task Force on the Prevention and Treatment of Obesity, 2000). Enormous public health implications derive from these facts, with almost 7% of the US health care budget spent on medical treatment of obesity-related conditions (Colditz, 1999).
Most studies state that schizophrenic patients tend to be overweight (Gopalaswamy and Morgan, 1985, Strassnig et al., 2003a). However, Allison et al. (1999) found this to be true primarily in women. It appears even more worrisome that adolescent and young adult patients with schizophrenia already carry more body weight than their corresponding healthy peers (Theisen et al., 2001). Weight gain in schizophrenia patients may well be attributed to medication effects (Ganguli, 1999), such as through appetite increase, sedation, or hormonal effects (Baptista, 1999, Taylor and McAskill, 2000). Lifestyle factors, e.g. poor diet, also contribute (Strassnig et al., 2003a, Strassnig et al., 2003b, Brown et al., 1999). There is also some evidence that obesity is an independent risk factor for antipsychotic noncompliance (Weiden et al., 2003), leaving the individual more vulnerable to relapse (Weiden and Olfson, 1995).
Even a moderate degree of weight reduction is beneficial to the overweight person (Blackburn, 1995) and significantly decreases health risks (Ross et al., 2000, Willet et al., 1999). Overweight schizophrenia patients may also benefit from weight loss, as they usually carry numerous additional risk factors for medical diseases, including a higher prevalence of smoking and diabetes (Brown et al., 2000).
A disturbed body size and body weight perception has long been noted in psychiatric patients, especially in patients with eating disorders (Becker et al., 1999, Warah, 1989, Birtchnell et al., 1985). Some evidence exists that patients with schizophrenia also mispercept their body size, but findings have been controversial (Fischer, 1986, Priebe and Röhricht, 2001) and may rather represent a specific feature of acute psychopathology in a distinct subset of patients (Rohricht and Priebe, 2002). Apart from the latter trials, it is notable that outside of the literature focusing on eating disorders, few studies have examined the relationship of weight perception and dieting behaviors in the psychiatric population.
In mentally healthy persons, there is a relationship between satisfaction with body size and engagement in weight loss efforts. Indeed, the strongest predictor of engagement in weight loss efforts in a healthy population has been the perceived body size (Anderson et al., 2002). It seems important to assess whether this is true for schizophrenia patients as well. We therefore decided to examine the relations, if any, between measured BMI, self-reported weight perception, expressed desire to lose weight and dieting behavior of schizophrenia patients.
Section snippets
Subjects
Patients with a DSM-IV diagnosis (APA, 1994) of Schizophrenia, Schizoaffective Disorder and Psychotic Disorder NOS were recruited from the outpatient clinic and partial hospital at the Comprehensive Care Services at the Western Psychiatric Institute and Clinic, Pittsburgh, PA. Patients were approached by one of the investigators during regular clinic hours, either before or after their scheduled therapist or psychiatrist appointment, and asked whether they were interested in participating in a
Results
We studied 143 patients with a diagnosis of schizophrenia, schizoaffective disorder, and psychotic disorder NOS. Average age in the study sample was 43.3 (±8.6) years. Seventy-seven patients (53.8%) were male, and 66 (46.2%) were female. Regarding ethnicity, 77 (53.8%) were Caucasian and 66 (46.2%) were African-American. Sixty-seven study subjects (46.9%) carried a diagnosis of DSM IV Schizophrenia, 52 (36.3%) of Schizoaffective Disorder, and 24 (16.8%) a diagnosis of Psychotic Disorder NOS.
Discussion
The perception of body weight was a function of body mass index. In contrast to popular belief, weight perception of obese schizophrenia patients enrolled in the study (those with a BMI≥30) was fairly accurate. Meyer (2002) found a similar pattern among inpatients who suffer from schizophrenia; obese inpatients understood that they weighted too much. They were also aware of the fact that something needed to be done about their body weight.
Only non-obese males (BMI category ≤29.9) had trouble
Acknowledgement
Funding for this study was provided by the Trunzo Family Fund at the University of Pittsburgh. The authors wish to acknowledge the assistance of Robert Wirth, RN with recruitment of research subjects. We also thank the staff of the Comprehensive Care Program and the Schizophrenia Treatment and Research Center at Western Psychiatric Institute and Clinic for their assistance with recruitment.
References (51)
- et al.
Cardiovascular complications of weight reduction diets
Am. J. Med. Sci.
(2001) - et al.
Relationship of satisfaction with body size and trying to lose weight in a national survey of overweight and obese women aged 40 and older, United States
Prev. Med.
(2002) - et al.
Comparing patient and physician perception of weight status with body mass index
Am. J. Med.
(2002) - et al.
Self perception of weight appropriateness in the United States
Am. J. Prev. Med.
(2003) - et al.
Popular diets: correlation to health, nutrition, and obesity
J. Am. Diet. Assoc.
(2001) - et al.
Counseling to promote a healthy diet in adults: a summary of the evidence of the U.S. Preventive Services Task Force
Am. J. Prev. Med.
(2003) Psychological consequences of food restriction
J. Am. Diet. Assoc.
(1996)- et al.
Specific body image pathology in acute schizophrenia
Psychiatry Res.
(2001) - et al.
Body mass index and quality of life in community-dwelling patients with schizophrenia
Schizophr. Res.
(2003) - et al.
Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication
J. Psychiatr. Res.
(2001)
The distribution of body mass index among individuals with and without schizophrenia
J. Clin. Psychiatry
Diagnostic and Statistical Manual
A weight management program for treatment of olanzapine-related weight gain
Psychiatr. Serv.
Body weight gain induced by antipsychotic drugs: mechanisms and management
Acta Psychiatr. Scand.
Current concepts: eating disorders
N. Engl. J. Med.
Body image distortion in bulimia nervosa
Br. J. Psychiatry
Effect of degree of weight loss on health benefits
Obes. Res.
Perception of weight status and dieting behavior in Dutch men and women
Int. J. Obes.
The unhealthy lifestyle of people with schizophrenia
Psychol. Med.
Causes of excess mortality in schizophrenia
Br. J. Psychiatry
Economic costs of obesity and inactivity
Med. Sci. Sports Exercise
Lay definitions of ideal weight and overweight
Int. J. Obes.
Does counseling by clinicians improve physical activity. A summary of evidence for the U.S. Preventive Services Task Force
Ann. Intern. Med.
Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults
Arch. Intern. Med.
Development and Structure of the Body Image. Vols. 1 and 2
Cited by (43)
Body image and paranoia
2017, Psychiatry ResearchIndividual Factors Affecting Self-esteem, and Relationships Among Self-esteem, Body Mass Index, and Body Image in Patients With Schizophrenia
2017, Archives of Psychiatric NursingCitation Excerpt :Continuous use of schizophrenia medication increases discharge rates, and reduces re-admission, which demonstrates the importance of medication compliance. However, atypical drugs have side effects, such as cardiovascular disease, weight gain, and type 2 diabetes mellitus (Lan & Chen, 2012; Strassnig, Brar, & Ganguli, 2005), and these drugs are purportedly the primary cause of obesity seen in patients with schizophrenia (Liu et al., 2010; Ventriglio et al., 2014). Typical drugs block only the dopamine pathway, whereas atypical drugs block not only dopamine but also serotonin.
Lifestyle Intervention for People with Severe Obesity and Serious Mental Illness
2016, American Journal of Preventive MedicineEffects of a group physical activity program on physical fitness and quality of life in individuals with schizophrenia
2014, Mental Health and Physical ActivityCitation Excerpt :People with schizophrenia experience greater health problems than the general population (Hennekens, Hennekens, Hollar, & Casey, 2005; Roick et al., 2007). This condition is associated with a sedentary lifestyle, with a poor diet intake, and with the use of alcoholic beverages and smoking addiction which is on average, 3 to 4 times higher when compared to the general population (Faulkner & Biddle, 1999; Janney et al., 2013; Strassnig, Brar, & Ganguli, 2005; Van Os & Kapur, 2009). Furthermore, the majority of this population uses antipsychotic drugs that may produce weight gain (Gothelf et al., 2002; Henderson et al., 2006).
Physical performance and disability in schizophrenia
2014, Schizophrenia Research: Cognition